066700 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. It operates through the following business divisions: Pharmaceutical, Specialized drug distribution, Healthcare and Genome. It offers cimetidine tabs, dimetal tabs, gabamin tabs, aclfen tab, hydone tab, other pharmaceutical products and genome analysis services. The company was founded on September 27, 1990 and is headquartered in Ansan-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
066700 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company